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Abstract: The effect of marine polyunsaturated fatty acids on biofilm formation by the 
human  pathogens  Candida  albicans  and  Candida  dubliniensis  was  investigated.  It  was 
found that stearidonic acid (18:4 n-3), eicosapentaenoic acid (20:5 n-3), docosapentaenoic 
acid  (22:5  n-3)  and  docosahexaenoic  acid  (22:6  n-3)  have  an  inhibitory  effect  on 
mitochondrial metabolism of both C. albicans and C. dubliniensis and that the production 
of  biofilm  biomass  by  C. dubliniensis  was  more  susceptible  to  these  fatty  acids  than 
C. albicans. Ultrastructural differences, which may be due to increased oxidative stress, 
were observed between treated and untreated cells of C. albicans and C. dubliniensis with 
formation of rough cell walls by both species and fibrillar structures in C. dubliniensis. 
These  results  indicate  that  marine  polyunsaturated  fatty  acids  may  be  useful  in  the 
treatment and/or prevention of biofilms formed by these pathogenic yeasts. 
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1. Introduction 
Candida albicans and Candida dubliniensis are dimorphic yeasts, able to grow both as yeasts and 
mycelia. Several members of the genus Candida exist as commensals of the human gastrointestinal and 
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genitourinary tract in healthy individuals [1–3]. However, in individuals whose immune system is 
compromised,  such  as  those  that  are  HIV  positive,  C.  albicans  can  cause  diseases  ranging  from 
superficial infections to deep seated mycoses [4,5]. Candida dubliniensis is a species closely related to 
C. albicans and a causative agent of oropharyngeal candidiasis in immunocompromised humans [5,6]. 
Biofilm formation is a major virulence factor in the pathogenicity of Candida species, partly due to 
their increased resistance to antifungal treatment [7,8]. Since biofilm associated infections have many 
clinical and economic consequences, recent research into the pathogenicity of Candida species has 
focused on the prevention and management of these biofilms. Fatty acids have been known to have 
antibacterial [9] and antifungal properties and especially capric acid (10:0) and lauric acid (12:0) are 
known to have anti-Candida effects by inhibiting growth of planktonic cells [10] and butyric acid (4:0) 
was shown to inhibit hyphal formation by C. albicans [11].  
Marine lipids, such as fish oils, are well known sources of medium to long chain polyunsaturated 
fatty acids (PUFAs) and are enriched in n-3 PUFAs [i.e., stearidonic acid (18:4 n-3), eicosapentaenoic 
acid  (20:5  n-3),  docosapentaenoic  acid  (22:5  n-3)  and  docosahexaenoic  acid  (22:6  n-3)]  [12].  In 
addition, marine algae provide alternative sources of these n-3 PUFAs [13]. The lipid compositions 
and quantity of marine lipids vary depending on species and climatic conditions, with lipids from 
organisms in colder regions having a higher PUFA content than those in warmer regions [14,15]. 
Although  some  marine  PUFAs  have  beneficial  effects  in  several  human  diseases  [16–18],  the 
effectiveness  of  marine  PUFAs  against  Candida  biofilms  have  not  been  assessed  previously. 
Therefore, the aim of this study was to determine the effect of long chain marine PUFAs [18:4 n-3, 
arachidonic acid (20:4 n-6), 20:5 n-3, 22:5 n-3 and 22:6 n-3] on biofilm formation by C. albicans and 
C. dubliniensis. 
2. Results and Discussion  
2.1. Inhibition of mitochondrial metabolism 
Figure 1. Effect of marine fatty acids (18:4 n-3, 20:4 n-3, 20:5 n-3, 22:5 n-3, 22:6 n-3) on 
mitochondrial  metabolism  of  C.  albicans  and  C.  dubliniensis  biofilms.  Biofilms  were 
grown in the presence of 1 mM of the fatty acids and mitochondrial activity was monitored 
using  the  XTT  assay.  The  percentage  inhibition  values  were  determined  compared  to 
untreated controls. n = 8; * significantly different from control (P ≤ 0.01).  
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As  indicated  in  Figure  1  the  mitochondrial  metabolism  of  biofilms  of  C.  albicans  and 
C. dubliniensis, assessed by XTT assay, was significantly inhibited by 1 mM 18:4 n-3, 20:5 n-3 and 
22:5  n-3.  In  addition,  biofilms  of  C.  albicans  were  also  sensitive  to  20:4  n-6,  while  biofilms  of 
C. dubliniensis  were not  significantly inhibited. Interestingly, 22:6 n-3 did not significantly inhibit 
mitochondrial metabolism of C. albicans or C. dubliniensis biofilms. As a result 20:4 n-6 and 22:6 n-3 
were not used in further experiments. 
2.2. Inhibition of biomass production 
Although several authors use the XTT reduction assay as an indicator of biofilm biomass, Kuhn and 
co-workers [19] has cautioned against this approach. Therefore, the effect of the marine PUFAs on 
biofilm biomass production was determined by dry weight. As indicated in Figure 2, biofilm biomass 
production by C. dubliniensis was susceptible to the three tested PUFAs, with 18:4 n-3 and 20:5 n-3 
resulting in a reduction of circa 82% and 71%, respectively. C. dubliniensis biofilm biomass was less 
susceptible to 22:5 n-3, which produced an inhibition of circa 19%. Similar results were obtained 
between the two species for the XTT reduction assay, however, the biofilm biomass of C. albicans was 
generally less susceptible to the tested PUFAs and a reduction of only circa 25% and 22% was seen for 
18:4 n-3 and 22:5 n-3, respectively. Although a circa 16% reduction in C. albicans biofilm biomass 
was  observed  with  20:5  n-3,  this  was  not  statistically  significant.  These  results  may  indicate  the 
increased  ability  of  the  C.  albicans  strain  to  obtain  energy  through  pathways  that  do  not  require 
mitochondrial metabolism. 
Figure 2. Inhibition of biofilm biomass of C. albicans and C. dubliniensis compared to 
untreated controls. Biofilms were grown in the presence of 1 mM of the marine PUFAs 
(18:4 n-3, 20:5  n-3, 22:5  n-3) and biofilm dry weight was determined on pre-weighed 
filters. n = 2. 
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2.3. Morphology of cells in biofilms 
Figure 3 depicts biofilms of C. albicans grown in the presence and absence of 1 mM 18:4 n-3,  
20:5 n-3 and 22:5 n-3. In the absence of the PUFAs, the cell surface appeared smooth (Figure 3a) and 
when grown in the presence of PUFAs, cells had a rough appearance with protuberances (Figure 3b, c, d). 
Similar results were also observed for biofilms of C. dubliniensis when grown in the absence (Figure 4a), Mar. Drugs 2010, 8  
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and the presence (Figure 4b, c, d), of the PUFAs with protuberances and fibrillar structures visible on 
the  cell  surface.  Similar  rough  cell  surfaces  were  observed  when  C.  albicans  was  exposed  to 
miconazole [20], which is known to cause an increase in reactive oxygen species in Candida biofilm 
cells [21]. Lemar et al. [22] also found that C. albicans cells were not smooth in the presence of alyl 
alcohol, which increases oxidative stress. Furthermore, in a study by Leeuw et al. [23] on the yeast 
Cryptococcus curvatus grown on oxidised lipids, protuberances were observed on the cell surface. We 
therefore speculate that the changes in cell surface in the presence of PUFAs might be due to increased 
lipid peroxidation and resultant oxidative stress. This will be studied in future. 
Figure 3. SEM micrograps showing cells of C. albicans control biofilms (a) and biofilms 
treated with 1 mM 18:4 n-3 (b), 20:5 n-3 (c) and 22:5 n-3 (d). 
 
Figure  4.  SEM  micrographs showing cells  of  C.  dubliniensis control biofilms  (a) and 
biofilms treated with 1mM 18:4 n-3 (b), 20:5 n-3 (c) and 22:5 n-3 (d). 
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3. Experimental  
3.1. Strains used 
Candida albicans CBS 562T and Candida dubliniensis NRRL Y-17841T were used in this study 
and were maintained on yeast malt extract (YM) agar plates (10 g/L glucose, 3 g/L yeast extract,  
3 g/L malt extract, 5 g/L peptone, 16 g/L agar) at room temperature. The strains were stored on agar 
slants at 4 ° C. 
3.2. XTT assay of biofilms 
Cells of C. albicans and C. dubliniensis were grown separately on YM agar plates and incubated at 
30 ° C for 24 hours. After incubation, a loop-full of the cells was inoculated into 20 mL of yeast 
nitrogen base (YNB) glucose medium (10 g/L glucose, 6.7 g/L YNB) and incubated for 48 hours at 
30 ° C. Cells were washed three times with phosphate buffered saline (PBS) and diluted in RPMI-1640 
medium (Sigma-Aldrich, UK) to an initial cell concentration of 1 ×  10
6 cells/mL. A volume of 100 µL 
of  the  standardized  cell  suspension  was  dispensed  into  a  96-well  microtiter  plate  (Corning 
Incorporated, Costar
®, U.S.) and incubated for 1 hour at 37 ° C to allow adherence of cells to the 
surface [24]. Wells were washed twice with PBS to remove non-adherent cells. Mature biofilms were 
formed  at  37  ° C  for  47  hours  in  the  presence  and  absence  of  1  mM  of  the  marine  fatty  acids  
(18:4  n-3,  20:4  n-3,  20:5  n-3,  22:5  n-3,  22:6  n-3)  (Sigma-Aldrich,  UK).  The  reduction  of 
(2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide) (XTT) 
(Sigma Aldrich) was used to examine the yeast viability by measuring the mitochondrial metabolic 
activity  of  the  biofilms,  according  to  the  method  of  Kuhn  et  al.  [19].  XTT  is  converted  to  the 
diffusible, water soluble formazan that is colored and is easily measured in cellular supernatants in 
terms of optical density at 492 nm. This experiment was done in duplicate on two different days and 
four values obtained for each repetition (n = 8). The average and standard deviations were calculated 
and the student’s t-test was used to determine the significance of data sets. 
3.3. Biomass determination 
Twenty milliliters of a standardized cell suspension (1 ×  10
6 cells/mL), prepared as before, was 
inoculated into Petri dishes containing RPMI-1640 medium and allowed to adhere to the surface for 
1 hour at 37 ° C. Non-adherent cells were removed with PBS and mature biofilms were formed in the 
presence of 1 mM of the marine fatty acids (18:4 n-3, 20:5 n-3, 22:5 n-3) for 47 hours at 37 °C . 
Untreated biofilms served as controls. Mature biofilms were washed to remove non-adherent cells, 
scraped off and resuspended in PBS. Cells were filtered on pre-weighed 0.2 µm cellulose acetate filters 
(Lasec,  SA).  The  filters  were  dried  to  constant  weight  for  48  hours  at  37  °C   and  the  biomass 
determined. This experiment was done in duplicate and the mean and range calculated. 
3.4. Morphological examination  
The standardized cell suspension (1 ×  10
6 cells/mL), prepared as before, was added to chamber 
slides (Lab-Tek
® Chamber Slide™ System 177372) containing silicone rubber disks (diam 5.5 mm) Mar. Drugs 2010, 8  
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and 4 mL RPMI-1640 medium. Cells were allowed to adhere for 1 hour at 37 ° C. Non-adherent cells 
were removed with PBS and mature biofilms were formed in the presence of 1 mM of the marine fatty 
acids (18:4 n-3, 20:5 n-3, 22:5 n-3) for 47 hours at 37 °C , with appropriate controls. The silicone 
rubber disks were removed and fixed for 2 hours using 3% (v/v; 1.0 M) sodium phosphate buffered 
glutardialdehyde, followed by fixing for 1 hour with a similarly buffered solution of osmium tetroxide 
(1% m/v). The disks were dehydrated in a graded series of ethanol solutions (50%, 70% and 95%) for 
20 minutes and absolute ethanol for 1 hour. They were then critical-point dried, mounted and coated 
with gold to make them electrically conductive and finally visualized on a Shimadzu SSX550 SEM 
(Japan) microscope according to the method of van Wyk and Wingfield [25].  
4. Conclusions 
Certain marine PUFAs, especially 18:4 n-3, 20:5 n-3 and 22:5 n-3, have an inhibitory effect on the 
mitochondrial activity of both  C. albicans  and  C. dubliniensis biofilms and significantly inhibited 
biofilm biomass of C. dubliniensis. These marine PUFAs also affected cellular morphology of biofilms 
of both species. This may be due to increased oxidative stress as a result of incorporation of PUFAs 
into the cellular lipids. These findings suggest that marine PUFAs may be useful in the treatment 
and/or  prevention  of  Candida  biofilms,  which  are  known  to  have  increased  antifungal  resistance 
compared to free-living cells. 
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